NCT Number: NCT02059954
Vaginal vs. Laparoscopic Hysterectomy
Hysterectomy for benign indication is one of the most common surgical procedures in women. Numerous reviews and guidelines recommend the vaginal approach for benign hysterectomy, but the proportion of laparoscopic (and robotic) hysterectomies is increasing.
This study will compare a range of clinical and subjective outcomes of vaginal vs. total laparoscopic hysterectomy. Outcomes include operating time, postoperative recovery, return to work as well as cosmesis, quality of life and sexual health.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–80 year
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
Primary location
Krankenhaus der Barmherzigen Brüder, Abteilung Gynäkologie, Graz, Austria
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- benign indication for vaginal hysterectomy (e.g., abnormal uterine bleeding, fibroids, atypical endometrial hyperplasia)
- clinical exam indicates vaginal hysterectomy is feasible
- no major concomitant surgery
- able to complete questionnaires in German
Exclusion criteria
- uterine malignancy
- major concomitant surgery (e.g., for incontinence or prolapse)
- clinical exam indicating vaginal hysterectomy not feasible
- contraindication for surgery or laparoscopy
Treatment and study plan
Primary outcomes
-
Operating time (min.)
Time frame: Surgery
Operating time (min.)
Secondary outcomes
-
Complications
Time frame: 6 weeks
Intraoperative and postoperative complications
-
Anesthesia time (min.)
Time frame: surgery
-
Quality of life
Time frame: 12 months
-
Sexual health
Time frame: 12 months
-
Return to work
Time frame: 3 months
Sponsors and collaborators
Lead sponsor
Medical University of Graz
Other
Collaborators
- Austrian Urogynecology Working Group (AUWG)
Registry information
Official study title
Vaginal Hysterectomy Versus Total Laparoscopic Hysterectomy for Benign Indications: A Randomized Controlled Trial
Important dates
- Study start
- 2014
- Primary completion
- 2016
- Study completion
- 2017
- First posted
- Feb 11, 2014
- Registry last updated
- Apr 17, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
NCT03751124
Connective Tissue Diseases, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial DetailsMR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
NCT00365989
Connective Tissue Diseases, Leiomyoma
La Jolla, California, United States
View Trial DetailsPreoperative Administration of EGCG, Vitamin D and DCI Prior Hysteroscopic Myomectomy
NCT06768086
Behavior, Connective Tissue Diseases
Scorrano, Lecce, Italy
View Trial DetailsMinimally Invasive Benign Hysterectomy
NCT01865929
Cervical Dysplasia, Female Urogenital Diseases
Lund, Sweden
View Trial Details